BRPI0512547A - pirimidinas - Google Patents
pirimidinasInfo
- Publication number
- BRPI0512547A BRPI0512547A BRPI0512547-2A BRPI0512547A BRPI0512547A BR PI0512547 A BRPI0512547 A BR PI0512547A BR PI0512547 A BRPI0512547 A BR PI0512547A BR PI0512547 A BRPI0512547 A BR PI0512547A
- Authority
- BR
- Brazil
- Prior art keywords
- pyrimidines
- akt
- isoforms
- formula
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
PIRIMIDINAS. A presente invenção refere-se a novos derivados de pirimidina que são inibidores eficazes de proteína quinases, em particular de uma ou mais isoformas da proteína quinase B/Akt.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04103011 | 2004-06-28 | ||
EP05102355 | 2005-03-23 | ||
PCT/EP2005/053019 WO2006000589A1 (en) | 2004-06-28 | 2005-06-28 | 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0512547A true BRPI0512547A (pt) | 2008-03-25 |
Family
ID=34973043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0512547-2A BRPI0512547A (pt) | 2004-06-28 | 2005-06-28 | pirimidinas |
Country Status (16)
Country | Link |
---|---|
US (1) | US7879853B2 (pt) |
EP (1) | EP1763526B1 (pt) |
JP (1) | JP5065017B2 (pt) |
KR (1) | KR20070027723A (pt) |
CN (1) | CN1972934A (pt) |
AT (1) | ATE434614T1 (pt) |
AU (1) | AU2005256659A1 (pt) |
BR (1) | BRPI0512547A (pt) |
CA (1) | CA2570552A1 (pt) |
DE (1) | DE602005015110D1 (pt) |
ES (1) | ES2328601T3 (pt) |
IL (1) | IL179883A0 (pt) |
MX (1) | MXPA06014747A (pt) |
NO (1) | NO20070334L (pt) |
WO (1) | WO2006000589A1 (pt) |
ZA (1) | ZA200609637B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6907921B2 (en) | 1998-06-18 | 2005-06-21 | 3M Innovative Properties Company | Microchanneled active fluid heat exchanger |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US8003651B2 (en) | 2006-07-06 | 2011-08-23 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
US20100120717A1 (en) | 2006-10-09 | 2010-05-13 | Brown Jason W | Kinase inhibitors |
US20090012434A1 (en) * | 2007-07-03 | 2009-01-08 | Anderson Robert S | Apparatus, method, and system to treat a volume of skin |
US7982036B2 (en) * | 2007-10-19 | 2011-07-19 | Avila Therapeutics, Inc. | 4,6-disubstitued pyrimidines useful as kinase inhibitors |
AU2012236166A1 (en) | 2011-04-01 | 2013-11-14 | Genentech, Inc. | Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use |
ES2688809T3 (es) | 2011-04-01 | 2018-11-07 | Genentech, Inc. | Combinaciones de compuestos inhibidores de AKT y MEK para tratar el cáncer |
AR088570A1 (es) * | 2011-10-28 | 2014-06-18 | Celgene Avilomics Res Inc | Metodos para tratar una enfermedad o trastorno relacionado con la tirosina quinasa de bruton |
AU2012321091B2 (en) * | 2011-10-28 | 2016-05-12 | Celgene Avilomics Research, Inc. | Methods of treating a Bruton's Tyrosine Kinase disease or disorder |
KR20140139547A (ko) * | 2012-04-04 | 2014-12-05 | 암젠 인크 | 헤테로사이클릭 화합물 및 그의 용도 |
US9561228B2 (en) | 2013-02-08 | 2017-02-07 | Celgene Avilomics Research, Inc. | ERK inhibitors and uses thereof |
US9993460B2 (en) | 2013-07-26 | 2018-06-12 | Race Oncology Ltd. | Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
CN103601675B (zh) * | 2013-10-08 | 2015-10-28 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
CN103483250B (zh) * | 2013-10-08 | 2015-07-22 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
EP3179858B1 (en) | 2014-08-13 | 2019-05-15 | Celgene Car Llc | Forms and compositions of an erk inhibitor |
CN113509471B (zh) * | 2021-07-19 | 2023-06-13 | 中国药科大学 | Akt2抑制剂在制备治疗阿霉素引发心肌损伤药物中的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW321649B (pt) | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
ZA986732B (en) | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitiors of tyrosine kinases |
JP2001522853A (ja) | 1997-11-11 | 2001-11-20 | ファイザー・プロダクツ・インク | 抗癌剤として有用なチエノピリミジンおよびチエノピリジン誘導体 |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
US20020065270A1 (en) * | 1999-12-28 | 2002-05-30 | Moriarty Kevin Joseph | N-heterocyclic inhibitors of TNF-alpha expression |
JP4794793B2 (ja) * | 1999-12-28 | 2011-10-19 | ファーマコペイア, インコーポレイテッド | N−ヘテロ環TNF−α発現阻害剤 |
IL154240A0 (en) | 2000-08-08 | 2003-07-31 | Ortho Mcneil Pharm Inc | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
AR035967A1 (es) | 2001-05-18 | 2004-07-28 | Altana Pharma Ag | Un compuesto de piridilmetilaminopirimidina, un medicamento que lo comprende y el uso del mismo |
EP1448556A1 (en) * | 2001-11-01 | 2004-08-25 | Janssen Pharmaceutica N.V. | Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
KR20050040814A (ko) | 2001-11-01 | 2005-05-03 | 얀센 파마슈티카 엔.브이. | 글리코겐 신타아제 키나제 3-베타 저해제로서의 아미드유도체 |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
AU2003206397B2 (en) | 2002-01-04 | 2008-07-17 | The Rockefeller University | Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
DK2316831T3 (da) | 2002-11-21 | 2013-06-10 | Novartis Ag | 2-(Morpholin-4-yl)pyrimidiner som phosphotidylinositol (PI)-3-kinaseinhibitorer samt deres anvendelse ved behandling af cancer |
WO2005026129A1 (en) | 2003-09-15 | 2005-03-24 | Gpc Biotech Ag | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
EP1709007A1 (en) | 2004-01-22 | 2006-10-11 | Altana Pharma AG | N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors |
JP2008542219A (ja) * | 2005-05-25 | 2008-11-27 | インゲニウム ファーマシューティカルズ ジーエムビーエイチ | 疼痛処置法 |
-
2005
- 2005-06-28 CA CA002570552A patent/CA2570552A1/en not_active Abandoned
- 2005-06-28 JP JP2007517306A patent/JP5065017B2/ja not_active Expired - Fee Related
- 2005-06-28 US US11/630,352 patent/US7879853B2/en not_active Expired - Fee Related
- 2005-06-28 DE DE602005015110T patent/DE602005015110D1/de active Active
- 2005-06-28 MX MXPA06014747A patent/MXPA06014747A/es not_active Application Discontinuation
- 2005-06-28 AT AT05769611T patent/ATE434614T1/de not_active IP Right Cessation
- 2005-06-28 BR BRPI0512547-2A patent/BRPI0512547A/pt not_active IP Right Cessation
- 2005-06-28 EP EP05769611A patent/EP1763526B1/en active Active
- 2005-06-28 KR KR1020077001451A patent/KR20070027723A/ko not_active Application Discontinuation
- 2005-06-28 WO PCT/EP2005/053019 patent/WO2006000589A1/en active Application Filing
- 2005-06-28 AU AU2005256659A patent/AU2005256659A1/en not_active Abandoned
- 2005-06-28 ES ES05769611T patent/ES2328601T3/es active Active
- 2005-06-28 CN CNA2005800205458A patent/CN1972934A/zh active Pending
-
2006
- 2006-11-20 ZA ZA200609637A patent/ZA200609637B/xx unknown
- 2006-12-06 IL IL179883A patent/IL179883A0/en unknown
-
2007
- 2007-01-18 NO NO20070334A patent/NO20070334L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL179883A0 (en) | 2007-05-15 |
CA2570552A1 (en) | 2006-01-05 |
WO2006000589A1 (en) | 2006-01-05 |
ATE434614T1 (de) | 2009-07-15 |
NO20070334L (no) | 2007-03-28 |
DE602005015110D1 (de) | 2009-08-06 |
ZA200609637B (en) | 2008-08-27 |
EP1763526A1 (en) | 2007-03-21 |
JP2008504251A (ja) | 2008-02-14 |
JP5065017B2 (ja) | 2012-10-31 |
US7879853B2 (en) | 2011-02-01 |
US20070208034A1 (en) | 2007-09-06 |
ES2328601T3 (es) | 2009-11-16 |
AU2005256659A1 (en) | 2006-01-05 |
CN1972934A (zh) | 2007-05-30 |
MXPA06014747A (es) | 2007-02-16 |
EP1763526B1 (en) | 2009-06-24 |
WO2006000589A8 (en) | 2006-11-16 |
KR20070027723A (ko) | 2007-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0512547A (pt) | pirimidinas | |
NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
ATE346070T1 (de) | Purinderivate als kinaseinhibitoren | |
TW200801008A (en) | Protein kinase inhibitors | |
NO20070526L (no) | Kinazolindionderivater som parp-inhibitorer | |
ATE554087T1 (de) | Neue kinaseinhibitoren | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
ATE474835T1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyrimidine | |
NO20082508L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
ATE508126T1 (de) | Als kinaseinhibitoren geeignete aminopyrimidine | |
DK1567522T3 (da) | Pyrimidinforbindelser | |
NO20072567L (no) | Triazoler nyttige som proteinkinase-inhibitorer | |
WO2009006389A3 (en) | Pyrimidine derivatives useful as raf kinase inhibitors | |
DK1791830T3 (da) | Diaminotriazol-forbindelser der er nyttige som protein-kinase-inhibitorer | |
NO20076502L (no) | Pyrrolopyridiner nyttige som inhibitorer av proteinkinase | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
NO20070532L (no) | Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer | |
ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
ATE548363T1 (de) | 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen | |
ATE419253T1 (de) | Inhibitoren von thienopyridin- und furopyridinkinase | |
ATE435858T1 (de) | Prodrugs von als erk-proteinkinase-inhibitoren wirkenden pyrrolylpyrimidinen | |
MXPA05013076A (es) | Compuestos de isoindolina-1-ona como inhibidores de cinasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: NYCOMED GMBH (DE) Free format text: ALTERADO DE: ALTANA PHARMA AG |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER SCHERING PHARMA AG (DE) Free format text: TRANSFERIDO DE: NYCOMED GMBH |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |